Ipswich Investment Management Co. Inc. Sells 960 Shares of Colgate-Palmolive (NYSE:CL)

Ipswich Investment Management Co. Inc. cut its position in shares of Colgate-Palmolive (NYSE:CL) by 7.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 11,902 shares of the company’s stock after selling 960 shares during the quarter. Ipswich Investment Management Co. Inc.’s holdings in Colgate-Palmolive were worth $1,082,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Chicago Partners Investment Group LLC lifted its stake in shares of Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after purchasing an additional 943 shares during the period. Peak Financial Advisors LLC bought a new stake in Colgate-Palmolive in the fourth quarter worth approximately $1,315,000. Gordian Advisors LLC acquired a new position in Colgate-Palmolive in the third quarter valued at approximately $602,000. Carrera Capital Advisors boosted its holdings in shares of Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after buying an additional 7,353 shares in the last quarter. Finally, Fiduciary Alliance LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $4,066,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $89.56 on Friday. The business’s fifty day simple moving average is $88.94 and its 200 day simple moving average is $95.91. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12 month low of $84.45 and a 12 month high of $109.30. The firm has a market capitalization of $72.68 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the business posted $0.87 EPS. As a group, analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CL shares. Raymond James reiterated an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Finally, Morgan Stanley decreased their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.